Global Non- Alcoholic Steatohepatitis Treatment Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Non- Alcoholic Steatohepatitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non- Alcoholic Steatohepatitis Treatment.
The Non- Alcoholic Steatohepatitis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Non- Alcoholic Steatohepatitis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non- Alcoholic Steatohepatitis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non- Alcoholic Steatohepatitis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Non- Alcoholic Steatohepatitis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Non- Alcoholic Steatohepatitis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non- Alcoholic Steatohepatitis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Gilead Sciences
- Bristol Myers Squibb
- Novo Nordisk
- NGM Biopharmaceuticals
- Galectin Therapeutics
- Inventiva Pharma
- Intercept Pharmaceuticals
- AbbVie
- Madrigal Pharmaceuticals
- Cenicriviroc
- Aramchol
- Resmetirom
- Semaglutide
- Lanifibranor
- Obeticholic Acid (OCA)
- Retail & Specialty Pharmacies
- Hospital Pharmacies
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non- Alcoholic Steatohepatitis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cenicriviroc
1.2.3 Aramchol
1.2.4 Resmetirom
1.2.5 Semaglutide
1.2.6 Lanifibranor
1.2.7 Obeticholic Acid (OCA)
1.3 Market by Application
1.3.1 Global Non- Alcoholic Steatohepatitis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Retail & Specialty Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Non- Alcoholic Steatohepatitis Treatment Market Perspective (2018-2029)
2.2 Non- Alcoholic Steatohepatitis Treatment Growth Trends by Region
2.2.1 Global Non- Alcoholic Steatohepatitis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Non- Alcoholic Steatohepatitis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Non- Alcoholic Steatohepatitis Treatment Market Dynamics
2.3.1 Non- Alcoholic Steatohepatitis Treatment Industry Trends
2.3.2 Non- Alcoholic Steatohepatitis Treatment Market Drivers
2.3.3 Non- Alcoholic Steatohepatitis Treatment Market Challenges
2.3.4 Non- Alcoholic Steatohepatitis Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Non- Alcoholic Steatohepatitis Treatment Players by Revenue
3.1.1 Global Top Non- Alcoholic Steatohepatitis Treatment Players by Revenue (2018-2023)
3.1.2 Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Non- Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non- Alcoholic Steatohepatitis Treatment Revenue
3.4 Global Non- Alcoholic Steatohepatitis Treatment Market Concentration Ratio
3.4.1 Global Non- Alcoholic Steatohepatitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non- Alcoholic Steatohepatitis Treatment Revenue in 2022
3.5 Non- Alcoholic Steatohepatitis Treatment Key Players Head office and Area Served
3.6 Key Players Non- Alcoholic Steatohepatitis Treatment Product Solution and Service
3.7 Date of Enter into Non- Alcoholic Steatohepatitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global Non- Alcoholic Steatohepatitis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2024-2029)
5 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global Non- Alcoholic Steatohepatitis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non- Alcoholic Steatohepatitis Treatment Market Size (2018-2029)
6.2 North America Non- Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
6.4 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Non- Alcoholic Steatohepatitis Treatment Market Size (2018-2029)
7.2 Europe Non- Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
7.4 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Non- Alcoholic Steatohepatitis Treatment Market Size (2018-2029)
9.2 Latin America Non- Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
9.4 Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Introduction
11.1.4 Gilead Sciences Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.1.5 Gilead Sciences Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Detail
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Introduction
11.2.4 Bristol Myers Squibb Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Introduction
11.3.4 Novo Nordisk Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.3.5 Novo Nordisk Recent Development
11.4 NGM Biopharmaceuticals
11.4.1 NGM Biopharmaceuticals Company Detail
11.4.2 NGM Biopharmaceuticals Business Overview
11.4.3 NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Introduction
11.4.4 NGM Biopharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.4.5 NGM Biopharmaceuticals Recent Development
11.5 Galectin Therapeutics
11.5.1 Galectin Therapeutics Company Detail
11.5.2 Galectin Therapeutics Business Overview
11.5.3 Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Introduction
11.5.4 Galectin Therapeutics Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.5.5 Galectin Therapeutics Recent Development
11.6 Inventiva Pharma
11.6.1 Inventiva Pharma Company Detail
11.6.2 Inventiva Pharma Business Overview
11.6.3 Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Introduction
11.6.4 Inventiva Pharma Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.6.5 Inventiva Pharma Recent Development
11.7 Intercept Pharmaceuticals
11.7.1 Intercept Pharmaceuticals Company Detail
11.7.2 Intercept Pharmaceuticals Business Overview
11.7.3 Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Introduction
11.7.4 Intercept Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.7.5 Intercept Pharmaceuticals Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Non- Alcoholic Steatohepatitis Treatment Introduction
11.8.4 AbbVie Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.8.5 AbbVie Recent Development
11.9 Madrigal Pharmaceuticals
11.9.1 Madrigal Pharmaceuticals Company Detail
11.9.2 Madrigal Pharmaceuticals Business Overview
11.9.3 Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Introduction
11.9.4 Madrigal Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.9.5 Madrigal Pharmaceuticals Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cenicriviroc
1.2.3 Aramchol
1.2.4 Resmetirom
1.2.5 Semaglutide
1.2.6 Lanifibranor
1.2.7 Obeticholic Acid (OCA)
1.3 Market by Application
1.3.1 Global Non- Alcoholic Steatohepatitis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Retail & Specialty Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Non- Alcoholic Steatohepatitis Treatment Market Perspective (2018-2029)
2.2 Non- Alcoholic Steatohepatitis Treatment Growth Trends by Region
2.2.1 Global Non- Alcoholic Steatohepatitis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Non- Alcoholic Steatohepatitis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Non- Alcoholic Steatohepatitis Treatment Market Dynamics
2.3.1 Non- Alcoholic Steatohepatitis Treatment Industry Trends
2.3.2 Non- Alcoholic Steatohepatitis Treatment Market Drivers
2.3.3 Non- Alcoholic Steatohepatitis Treatment Market Challenges
2.3.4 Non- Alcoholic Steatohepatitis Treatment Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Non- Alcoholic Steatohepatitis Treatment Players by Revenue
3.1.1 Global Top Non- Alcoholic Steatohepatitis Treatment Players by Revenue (2018-2023)
3.1.2 Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Non- Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non- Alcoholic Steatohepatitis Treatment Revenue
3.4 Global Non- Alcoholic Steatohepatitis Treatment Market Concentration Ratio
3.4.1 Global Non- Alcoholic Steatohepatitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non- Alcoholic Steatohepatitis Treatment Revenue in 2022
3.5 Non- Alcoholic Steatohepatitis Treatment Key Players Head office and Area Served
3.6 Key Players Non- Alcoholic Steatohepatitis Treatment Product Solution and Service
3.7 Date of Enter into Non- Alcoholic Steatohepatitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT BREAKDOWN DATA BY TYPE
4.1 Global Non- Alcoholic Steatohepatitis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2024-2029)
5 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT BREAKDOWN DATA BY APPLICATION
5.1 Global Non- Alcoholic Steatohepatitis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non- Alcoholic Steatohepatitis Treatment Market Size (2018-2029)
6.2 North America Non- Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
6.4 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Non- Alcoholic Steatohepatitis Treatment Market Size (2018-2029)
7.2 Europe Non- Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
7.4 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Non- Alcoholic Steatohepatitis Treatment Market Size (2018-2029)
9.2 Latin America Non- Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
9.4 Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Introduction
11.1.4 Gilead Sciences Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.1.5 Gilead Sciences Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Detail
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Introduction
11.2.4 Bristol Myers Squibb Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Introduction
11.3.4 Novo Nordisk Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.3.5 Novo Nordisk Recent Development
11.4 NGM Biopharmaceuticals
11.4.1 NGM Biopharmaceuticals Company Detail
11.4.2 NGM Biopharmaceuticals Business Overview
11.4.3 NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Introduction
11.4.4 NGM Biopharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.4.5 NGM Biopharmaceuticals Recent Development
11.5 Galectin Therapeutics
11.5.1 Galectin Therapeutics Company Detail
11.5.2 Galectin Therapeutics Business Overview
11.5.3 Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Introduction
11.5.4 Galectin Therapeutics Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.5.5 Galectin Therapeutics Recent Development
11.6 Inventiva Pharma
11.6.1 Inventiva Pharma Company Detail
11.6.2 Inventiva Pharma Business Overview
11.6.3 Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Introduction
11.6.4 Inventiva Pharma Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.6.5 Inventiva Pharma Recent Development
11.7 Intercept Pharmaceuticals
11.7.1 Intercept Pharmaceuticals Company Detail
11.7.2 Intercept Pharmaceuticals Business Overview
11.7.3 Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Introduction
11.7.4 Intercept Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.7.5 Intercept Pharmaceuticals Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Non- Alcoholic Steatohepatitis Treatment Introduction
11.8.4 AbbVie Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.8.5 AbbVie Recent Development
11.9 Madrigal Pharmaceuticals
11.9.1 Madrigal Pharmaceuticals Company Detail
11.9.2 Madrigal Pharmaceuticals Business Overview
11.9.3 Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Introduction
11.9.4 Madrigal Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
11.9.5 Madrigal Pharmaceuticals Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cenicriviroc
Table 3. Key Players of Aramchol
Table 4. Key Players of Resmetirom
Table 5. Key Players of Semaglutide
Table 6. Key Players of Lanifibranor
Table 7. Key Players of Obeticholic Acid (OCA)
Table 8. Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Region (2018-2023)
Table 12. Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Region (2024-2029)
Table 14. Non- Alcoholic Steatohepatitis Treatment Market Trends
Table 15. Non- Alcoholic Steatohepatitis Treatment Market Drivers
Table 16. Non- Alcoholic Steatohepatitis Treatment Market Challenges
Table 17. Non- Alcoholic Steatohepatitis Treatment Market Restraints
Table 18. Global Non- Alcoholic Steatohepatitis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Players (2018-2023)
Table 20. Global Top Non- Alcoholic Steatohepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non- Alcoholic Steatohepatitis Treatment as of 2022)
Table 21. Ranking of Global Top Non- Alcoholic Steatohepatitis Treatment Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Non- Alcoholic Steatohepatitis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Non- Alcoholic Steatohepatitis Treatment Product Solution and Service
Table 25. Date of Enter into Non- Alcoholic Steatohepatitis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2018-2023)
Table 29. Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2024-2029)
Table 31. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2018-2023)
Table 33. Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2024-2029)
Table 35. North America Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 50. Gilead Sciences Company Detail
Table 51. Gilead Sciences Business Overview
Table 52. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Product
Table 53. Gilead Sciences Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 54. Gilead Sciences Recent Development
Table 55. Bristol Myers Squibb Company Detail
Table 56. Bristol Myers Squibb Business Overview
Table 57. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Product
Table 58. Bristol Myers Squibb Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 59. Bristol Myers Squibb Recent Development
Table 60. Novo Nordisk Company Detail
Table 61. Novo Nordisk Business Overview
Table 62. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Product
Table 63. Novo Nordisk Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 64. Novo Nordisk Recent Development
Table 65. NGM Biopharmaceuticals Company Detail
Table 66. NGM Biopharmaceuticals Business Overview
Table 67. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product
Table 68. NGM Biopharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 69. NGM Biopharmaceuticals Recent Development
Table 70. Galectin Therapeutics Company Detail
Table 71. Galectin Therapeutics Business Overview
Table 72. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Product
Table 73. Galectin Therapeutics Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 74. Galectin Therapeutics Recent Development
Table 75. Inventiva Pharma Company Detail
Table 76. Inventiva Pharma Business Overview
Table 77. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Product
Table 78. Inventiva Pharma Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 79. Inventiva Pharma Recent Development
Table 80. Intercept Pharmaceuticals Company Detail
Table 81. Intercept Pharmaceuticals Business Overview
Table 82. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product
Table 83. Intercept Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 84. Intercept Pharmaceuticals Recent Development
Table 85. AbbVie Company Detail
Table 86. AbbVie Business Overview
Table 87. AbbVie Non- Alcoholic Steatohepatitis Treatment Product
Table 88. AbbVie Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 89. AbbVie Recent Development
Table 90. Madrigal Pharmaceuticals Company Detail
Table 91. Madrigal Pharmaceuticals Business Overview
Table 92. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product
Table 93. Madrigal Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 94. Madrigal Pharmaceuticals Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 1. Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cenicriviroc
Table 3. Key Players of Aramchol
Table 4. Key Players of Resmetirom
Table 5. Key Players of Semaglutide
Table 6. Key Players of Lanifibranor
Table 7. Key Players of Obeticholic Acid (OCA)
Table 8. Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Region (2018-2023)
Table 12. Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Region (2024-2029)
Table 14. Non- Alcoholic Steatohepatitis Treatment Market Trends
Table 15. Non- Alcoholic Steatohepatitis Treatment Market Drivers
Table 16. Non- Alcoholic Steatohepatitis Treatment Market Challenges
Table 17. Non- Alcoholic Steatohepatitis Treatment Market Restraints
Table 18. Global Non- Alcoholic Steatohepatitis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Players (2018-2023)
Table 20. Global Top Non- Alcoholic Steatohepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non- Alcoholic Steatohepatitis Treatment as of 2022)
Table 21. Ranking of Global Top Non- Alcoholic Steatohepatitis Treatment Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Non- Alcoholic Steatohepatitis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Non- Alcoholic Steatohepatitis Treatment Product Solution and Service
Table 25. Date of Enter into Non- Alcoholic Steatohepatitis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2018-2023)
Table 29. Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2024-2029)
Table 31. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2018-2023)
Table 33. Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2024-2029)
Table 35. North America Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 50. Gilead Sciences Company Detail
Table 51. Gilead Sciences Business Overview
Table 52. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Product
Table 53. Gilead Sciences Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 54. Gilead Sciences Recent Development
Table 55. Bristol Myers Squibb Company Detail
Table 56. Bristol Myers Squibb Business Overview
Table 57. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Product
Table 58. Bristol Myers Squibb Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 59. Bristol Myers Squibb Recent Development
Table 60. Novo Nordisk Company Detail
Table 61. Novo Nordisk Business Overview
Table 62. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Product
Table 63. Novo Nordisk Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 64. Novo Nordisk Recent Development
Table 65. NGM Biopharmaceuticals Company Detail
Table 66. NGM Biopharmaceuticals Business Overview
Table 67. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product
Table 68. NGM Biopharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 69. NGM Biopharmaceuticals Recent Development
Table 70. Galectin Therapeutics Company Detail
Table 71. Galectin Therapeutics Business Overview
Table 72. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Product
Table 73. Galectin Therapeutics Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 74. Galectin Therapeutics Recent Development
Table 75. Inventiva Pharma Company Detail
Table 76. Inventiva Pharma Business Overview
Table 77. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Product
Table 78. Inventiva Pharma Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 79. Inventiva Pharma Recent Development
Table 80. Intercept Pharmaceuticals Company Detail
Table 81. Intercept Pharmaceuticals Business Overview
Table 82. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product
Table 83. Intercept Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 84. Intercept Pharmaceuticals Recent Development
Table 85. AbbVie Company Detail
Table 86. AbbVie Business Overview
Table 87. AbbVie Non- Alcoholic Steatohepatitis Treatment Product
Table 88. AbbVie Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 89. AbbVie Recent Development
Table 90. Madrigal Pharmaceuticals Company Detail
Table 91. Madrigal Pharmaceuticals Business Overview
Table 92. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product
Table 93. Madrigal Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023) & (US$ Million)
Table 94. Madrigal Pharmaceuticals Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Non- Alcoholic Steatohepatitis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Cenicriviroc Features
Figure 4. Aramchol Features
Figure 5. Resmetirom Features
Figure 6. Semaglutide Features
Figure 7. Lanifibranor Features
Figure 8. Obeticholic Acid (OCA) Features
Figure 9. Global Non- Alcoholic Steatohepatitis Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Application: 2022 VS 2029
Figure 11. Retail & Specialty Pharmacies Case Studies
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Others Case Studies
Figure 14. Non- Alcoholic Steatohepatitis Treatment Report Years Considered
Figure 15. Global Non- Alcoholic Steatohepatitis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Non- Alcoholic Steatohepatitis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Players in 2022
Figure 19. Global Top Non- Alcoholic Steatohepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non- Alcoholic Steatohepatitis Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Non- Alcoholic Steatohepatitis Treatment Revenue in 2022
Figure 21. North America Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Non- Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2029)
Figure 23. United States Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Non- Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2029)
Figure 27. Germany Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Share by Region (2018-2029)
Figure 35. China Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Non- Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2029)
Figure 43. Mexico Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2029)
Figure 47. Turkey Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Gilead Sciences Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 50. Bristol Myers Squibb Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 51. Novo Nordisk Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 52. NGM Biopharmaceuticals Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 53. Galectin Therapeutics Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 54. Inventiva Pharma Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 55. Intercept Pharmaceuticals Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 56. AbbVie Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 57. Madrigal Pharmaceuticals Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Figure 1. Global Non- Alcoholic Steatohepatitis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Cenicriviroc Features
Figure 4. Aramchol Features
Figure 5. Resmetirom Features
Figure 6. Semaglutide Features
Figure 7. Lanifibranor Features
Figure 8. Obeticholic Acid (OCA) Features
Figure 9. Global Non- Alcoholic Steatohepatitis Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Application: 2022 VS 2029
Figure 11. Retail & Specialty Pharmacies Case Studies
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Others Case Studies
Figure 14. Non- Alcoholic Steatohepatitis Treatment Report Years Considered
Figure 15. Global Non- Alcoholic Steatohepatitis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Non- Alcoholic Steatohepatitis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Players in 2022
Figure 19. Global Top Non- Alcoholic Steatohepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non- Alcoholic Steatohepatitis Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Non- Alcoholic Steatohepatitis Treatment Revenue in 2022
Figure 21. North America Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Non- Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2029)
Figure 23. United States Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Non- Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2029)
Figure 27. Germany Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Non- Alcoholic Steatohepatitis Treatment Market Share by Region (2018-2029)
Figure 35. China Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Non- Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2029)
Figure 43. Mexico Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Market Share by Country (2018-2029)
Figure 47. Turkey Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Gilead Sciences Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 50. Bristol Myers Squibb Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 51. Novo Nordisk Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 52. NGM Biopharmaceuticals Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 53. Galectin Therapeutics Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 54. Inventiva Pharma Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 55. Intercept Pharmaceuticals Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 56. AbbVie Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 57. Madrigal Pharmaceuticals Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
